Clinical Trial Update: Reduced Anticoagulation Targets in ECLS (RATE) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (RATE) evaluating reduced anticoagulation targets during extracorporeal life support has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Respiratory Failure

Snippet

Sponsor: University Medical Center Groningen | Conditions: Heart Failure, Respiratory Failure | Phase 3 | Status: COMPLETED